Amgen deal

The Thousand Oaks, Calif., company and the Massachusetts Institute of Technology agreed to collaborate on undisclosed biological research initiatives. AMGN received certain patent and technology licensing rights to developments resulting from the collaboration in exchange for funding of up to $3 million a year for as many as 10 years. ...